|BBP -- USA Etf|| |
USD 37.35 1.02 2.66%
The entity has beta of 1.4055 which indicates as market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Virtus LifeSci will likely underperform.. Even though it is essential to pay attention to Virtus LifeSci Biotech
current price movements, it is always good to be careful when utilizing equity historical returns. Macroaxis philosophy towards measuring future performance of any etf is to check both, its past performance charts as well as the business as a whole, including all available technical indicators
. Virtus LifeSci Biotech Products ETF exposes twenty-one different technical indicators which can help you to evaluate its performance.
Virtus LifeSci Biotech Relative Risk vs. Return Landscape
If you would invest 4,035
in Virtus LifeSci Biotech Products ETF on November 13, 2018
and sell it today you would lose (299.42)
from holding Virtus LifeSci Biotech Products ETF or give up 7.42%
of portfolio value over 30
days. Virtus LifeSci Biotech Products ETF is generating negative expected returns assuming volatility of 2.7897% on return distribution over 30 days investment horizon. In other words, 25% of equities are less volatile than the company and above 99% of equities are expected to generate higher returns over the next 30 days.
Daily Expected Return (%)
Considering 30-days investment horizon, Virtus LifeSci Biotech Products ETF is expected to under-perform the market. In addition to that, the company is 2.18 times more volatile than its market benchmark. It trades about -0.05 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.05 per unit of volatility.
Virtus LifeSci Market Risk Analysis
Sharpe Ratio = -0.052
Virtus LifeSci Relative Performance Indicators
Estimated Market Risk
| || |
| || |
| || |
Based on monthly moving average Virtus LifeSci is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Virtus LifeSci
by adding it to a well-diversified
Over the last 30 days Virtus LifeSci Biotech Products ETF has generated negative risk-adjusted returns adding no value to investors with long positions.
|Fifty Two Week Low||35.0000|
|Fifty Two Week High||46.8000|